BR1101183A - formulações contendo ácido hialurÈnico - Google Patents

formulações contendo ácido hialurÈnico

Info

Publication number
BR1101183A
BR1101183A BR1101183A BR1101183A BR1101183A BR 1101183 A BR1101183 A BR 1101183A BR 1101183 A BR1101183 A BR 1101183A BR 1101183 A BR1101183 A BR 1101183A BR 1101183 A BR1101183 A BR 1101183A
Authority
BR
Brazil
Prior art keywords
hyaluronic acid
formulations containing
containing hyaluronic
formulations
acid
Prior art date
Application number
BR1101183A
Other languages
English (en)
Inventor
Rudolf Edgard Falk
Samuel Simon Asculai
Ehud Shmuel Klein
David Willian Harper
David Hochman
Don Purschke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1101183A priority Critical patent/BR1101183A/pt
Publication of BR1101183A publication Critical patent/BR1101183A/pt

Links

BR1101183A 1997-05-14 1997-05-14 formulações contendo ácido hialurÈnico BR1101183A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1101183A BR1101183A (pt) 1997-05-14 1997-05-14 formulações contendo ácido hialurÈnico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR1101183A BR1101183A (pt) 1997-05-14 1997-05-14 formulações contendo ácido hialurÈnico

Publications (1)

Publication Number Publication Date
BR1101183A true BR1101183A (pt) 2006-10-24

Family

ID=37137340

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1101183A BR1101183A (pt) 1997-05-14 1997-05-14 formulações contendo ácido hialurÈnico

Country Status (1)

Country Link
BR (1) BR1101183A (pt)

Similar Documents

Publication Publication Date Title
PT1283051E (pt) Formulacoes de insulina estaveis
DK0853945T3 (da) Flydende gonadotropinholdige formuleringer
KR100315371B1 (ko) 히알루론산을포함하는제형
MA24473A1 (fr) Formulations
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID22939A (id) Formulasi-formulasi farmasi yang mengandung vorikonozal
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
ID20807A (id) Asam sulfonilaminokarboksilat
DE69825147D1 (de) 2-amino-6-(2-substituierte-4-phenoxy)-substituierte-pyridine
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
ITMI951395A0 (it) Formulazioni di f-silicone
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
EE9900440A (et) Farmatseutilised kompositsioonid
ITMI941169A0 (it) Formulazioni farmaceutiche
EE200000330A (et) Farmatseutilised kompositsioonid
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
DE29706076U1 (de) Zahnmedizinischer Aufbaupfosten
BR1101183A (pt) formulações contendo ácido hialurÈnico
NO994436L (no) Farmasöytiske sammensetninger
IT1290442B1 (it) Composizione contenente acido ialuronico
BR1100830A (pt) Derivados de ácido heteroacético